Skip to content

Effect of guided mindfulness meditation on sensory sensitivity and thinking abilities in people with migraine, irritable bowel syndrome, and fibromyalgia

Assessment of the effect of guided mindfulness meditation on sensory hypersensitivity and cognitive function in patients with migraine, irritable bowel syndrome, and fibromyalgia: a randomized controlled study with extended follow-up - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103481
Enrollment
60
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Meditation group: Participants in the intervention arm will undergo guided mindfulness meditation sessions of 20 minutes duration, five times per week, for a total period of 12 weeks. C

Sponsors

G B Pant Institute of Postgraduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged eighteen to fifty five years diagnosed with migraine as per International Classification of Headache Disorders criteria, with comorbid irritable bowel syndrome and fibromyalgia, willing to provide informed consent and comply with study procedures.

Exclusion criteria

Exclusion criteria: Secondary headache disorders, severe psychiatric illness, cognitive impairment interfering with assessment, pregnancy or lactation, concurrent participation in another interventional study, or inability to comply with the intervention protocol.

Design outcomes

Primary

MeasureTime frame
Change in sensory hypersensitivity and cognitive function scores from baseline to post intervention.Timepoint: Baseline, six weeks and twelve weeks

Secondary

MeasureTime frame
Change in migraine related disability and symptom severity scores.Timepoint: Baseline, six weeks and twelve weeks

Countries

India

Contacts

Public ContactDr Manvi Lamba

Maulana Azad Medical College, Delhi

manvilamba234@gmail.com9205977668

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026